Bioconjugate Chemistry
Article
column chromatography eluting with 3:1 hexanes/EtOAc →
2:1 hexanes/EtOAc to afford 390 mg (87%) of the desired
product as a bright yellow solid.
NMR (125 MHz, CDCl3): 26.6, 28.1, 37.1, 38.5, 50.5, 76.5,
83.4, 112.4, 116.3, 129.3, 149.2, 158.0, 168.9. ESI MS (Calc M
+H = 338.21): 338.27.
1H NMR (500 MHz, CDCl3): 1.30 (br s, 3H), 1.51 (br s,
6H), 7.31 (d, 4H, J = 9 Hz), 8.22 (d, 4H, J = 9 Hz). 13C NMR
(125 MHz, CDCl3): 28.0, 28.3, 83.3, 119.1, 125.7, 143.4, 149.5.
ESI MS (Calc M+H = 375.13): 373.42.
Boc(aminooxy) BHQ1 (19). 183 mg of 18 was dissolved in
10 mL tetrahydrofuran. 271 mg of Fast Corinth V salt was
added followed by 2 mL MeOH to aid in solubility. The red−
brown suspension was stirred at room temperature overnight
and slowly became a dark red solution. Volatiles were removed
and the crude material was purified by column chromatography
eluting with 1:1 Hexanes/EtOAc → 1:3 Hexanes/EtOAc to
afford 47 mg (13%) of a dark red solid.
tert-Butyl 2-(4-((4-(ethoxycarbonyl)phenyl)diazenyl)-
phenyl)-2-phenylhydrazinecarboxylate (16). 300 mg of 15
was dissolved in 10 mL MeOH. A catalytic amount of 10%
palladium on carbon was added and the solution stirred at
room temperature overnight under a hydrogen atmosphere
(balloon), after which TLC showed consumption of starting
materials. The resulting solution was filtered through Celite and
washed with methanol and the filtrate concentrated to afford
the crude diamino product. The crude diamino product was
dissolved in 7 mL toluene and treated with 515 mg ethyl 4-
nitrosobenzoate36 and 270 μL acetic acid. The resulting
solution was stirred at 90 °C overnight under an argon
atmosphere. TLC indicated the formation of a bright orange
product. Volatiles were removed in vacuo and the crude
material purified by column chromatography eluting with 3:1
hexanes/EtOAc → 2:1 hexanes/EtOAc to afford 297 mg (58%)
of a bright red foam. An analytically pure sample was obtained
by recrystallization from methanol.
1H NMR (500 MHz, CDCl3): 1.47 (s, 9H), 1.92 (m, 2H),
2.51 (s, 3H), 2.70 (s, 3H), 3.10 (s, 3H), 3.39 (m, 2H), 3.54 (t,
3H, J = 7.5 Hz), 4.01 (s, 3H), 4.35 (s, 2H), 6.75 (d, 2H, J = 9
Hz), 7.39 (s, 1H), 7.47 (d, 1H, J = 6.5 Hz), 7.57 (d, 2H, J = 8
Hz), 7.66 (d, 1H, J = 8 Hz), 7.70 (s, 1H), 7.91 (d, 2H, J = 9
Hz), 8.41 (br s, 1H). 13C NMR (125 MHz, CDCl3): 16.9, 21.4,
27.0, 28.2, 36.8, 38.8, 50.3, 56.4, 76.6, 83.6, 99.3, 111.4, 119.0,
119.1, 124.4, 126.0, 133.6, 133.6, 141.6, 149.5, 151.1, 169.0. ESI
MS (Calc M+H = 649.31): 649.31.
Boc(aminooxy) BHQ2 (20). 230 mg of 18 was dissolved in
15 mL tetrahydrofuran. 854 mg of Fast Black K salt was added
followed by 3 mL MeOH to aid in solubility. The red-brown
suspension was stirred at room temperature for 2 h and slowly
became a dark purple solution. Volatiles were removed and the
crude material was purified by column chromatography eluting
with 1:1 hexanes/EtOAc → EtOAc to afford 237 mg (53%) of
a dark purple solid.
1H NMR (500 MHz, CDCl3): 1.33 (br s, 3H), 1.43 (t, 6H, J
= 7.5 Hz), 1.53 (br s, 6H), 4.41 (q, 4H, J = 7.5 Hz), 7.36 (d,
4H, J = 9 Hz), 7.91−7.96 (m, 8H), 8.18 (d, 4H, J = 8.5 Hz).
13C NMR (125 MHz, CDCl3): 14.4, 28.1, 28.4, 61.3, 82.4,
119.5, 122.5, 124.8, 130.6, 131.8, 148.1, 148.5, 155.3, 166.2. ESI
MS (Calc M+H = 637.28): 637.42.
tert-Butyl 2-((2-(4-((4-(dimethylamino)phenyl)diazenyl)-
phenylsulfonamido)ethyl)amino)-2-oxoethoxycarbamate
(17). 113 mg of Boc(aminooxy)acetic acid was dissolved in 6
mL CH2Cl2. To this solution, 125 mg EDCI hydrochloride and
88 mg HOAt were added followed by 230 μL triethylamine.
188 mg of N-(2-aminoethyl)-4-((4-(dimethylamino)phenyl)-
diazenyl) benzenesulfonamide37 was added and the resulting
suspension stirred overnight at room temperature. Solvents
were eliminated and the crude solid was purified by column
chromatography eluting with 3% MeOH in CH2Cl2 to afford
116 mg (38%) of a bright orange solid.
1H NMR (500 MHz, CDCl3): 1.47 (s, 9H), 1.93 (m, 2H),
3.11 (s, 3H), 3.40 (m, 2H), 3.55 (t, 3H, J = 7.5 Hz), 4.05 (s,
3H), 4.09 (s, 3H), 4.34 (s, 2H), 6.76 (dd, 2H, J = 7 Hz, 2 Hz),
7.46 (s, 1H), 7.50 (s, 1H), 7.64 (s, 1H), 7.93 (dd, 2H, J = 7 Hz,
2 Hz), 8.04 (dd, 2H, J = 7 Hz, 2 Hz), 8.37 (dd, 2H, J = 7 Hz, 2
Hz), 8.43 (br s, 1H). 13C NMR (125 MHz, CDCl3): 27.0, 28.2,
36.8, 38.9, 50.2, 56.8, 76.6, 83.5, 99.9, 101.0, 111.5, 123.8,
124.8, 126.3, 142.1, 144.5, 146.9, 148.4, 150.9, 152.0, 153.7,
156.5, 158.2, 169.1. ESI MS (Calc M+H = 651.29): 651.25.
DNA Conjugation. Removal of Protecting Groups. For
aminooxy modified DNA, the phthalimide group was removed
selectively with hydrazine as recommended in the literature.34
For hydrazide modified DNA, the trityl group was removed on
the DNA synthesizer using alternating 10 s cycles of
deprotection reagent (3% trichloroacetic acid in dichloro-
methane) and dichloromethane washes for 3 min. Commer-
cially available 3-formylindole utilizes no protection of the
aldehyde. For compounds 7−9 and 11−13, 20 mg of boc-
protected precursor 14−17 or 19−20 was dissolved in 1 mL of
1:1 dichloromethane/trifluoroacetic acid and shaken at room
temperature for 2 h to provide the free hydrazine or aminooxy
compound for conjugation. Volatiles were removed in vacuo
and the crude product was used for DNA labeling without
further purification.
1H NMR (500 MHz, CDCl3): 1.48 (s, 9H), 3.12 (s, 6H),
3.19 (t, 2H, J = 5 Hz), 3.40 (t, 2H, J = 5 Hz), 4.28 (s, 2H), 5.71
(br s, 1H), 6.75 (d, 2H, J = 9.5 Hz), 7.74 (s, 1H), 7.88−7.90
(m, 4H), 7.95 (d, 2H, J = 7 Hz), 8.25 (br s, 1H). 13C NMR
(125 MHz, CDCl3): 28.2, 38.5, 40.5, 43.6, 76.5, 83.8, 111.5,
122.7, 125.8, 128.0, 139.7, 143.6, 153.1, 155.6, 158.1, 169.8. ESI
MS (Calc M-H = 519.20): 519.19.
tert-Butyl 2-((3-(methyl(phenyl)amino)propyl)amino)-2-
oxoethoxycarbamate (18). 300 mg of Boc(aminooxy)acetic
acid was dissolved in 10 mL CH2Cl2. To this solution, 451 mg
of EDCI hydrochloride, 0.657 mL Et3N, and 0.515 mL N-
methyl-N-phenylpropane-1,3-diamine were added and the
resulting solution stirred overnight at room temperature. The
reaction was diluted with CH2Cl2, washed twice with water and
once with brine. The organic layer was dried over MgSO4,
filtered, and concentrated, then purified by silica column
chromatography eluting with 3:2 EtOAc/hexanes to afford 230
mg (43%) of a yellow oil.
DNA Labeling. A solution of approximately 25 mM of
desired label in 750 μL 9:1 dimethylformamide/water was
added to the DNA CPG. 7.5 μL of aniline was added and the
resulting solution was shaken at room temperature overnight.
The CPG was rinsed 4 × 500 μL dimethylformamide and 4 ×
500 μL acetonitrile. Labeled DNA was cleaved using standard
deprotection conditions (concentrated aqueous ammonia, 55
°C, overnight) and purified by HPLC. Purity of the collected
product was assessed by analytical HPLC.
1H NMR (500 MHz, CDCl3): 1.46 (s, 9H), 1.82−1.88 (m,
2H), 2.94 (s, 3H), 3.34−3.42 (m, 4H), 4.32 (s, 2H), 6.67−6.70
Fluorescence Experiments. Fluorescence of the hybrid-
ization buffer (10 mM MgCl2, 70 mM Tris·Borate, pH 7.55)
(m, 3H), 7.20−7.24 (m, 2H), 7.53 (s, 1H), 8.25 (br s, 1H). 13
C
1972
dx.doi.org/10.1021/bc300344b | Bioconjugate Chem. 2012, 23, 1969−1980